John tozzi Bloomberg

The acquisition of One Medical would be Amazon’s third-biggest to date, after Whole Foods Market and MGM.

The Food and Drug Administration advised vaccine manufacturers to develop COVID-19 boosters tailored to the currently circulating Omicron variants for new shots that could be ready as soon as this fall.

The FDA is expected to decide by June 7 if aducanumab works well enough to allow it on the market. But approval would trigger a series of questions about who will get the new drug, how they’ll get it, how much it will cost, and who will pay for it.